New drug raises hope for cystic fibrosis patientsSeptember 10th, 2008 - 2:07 pm ICT by ANI
Washington, Sept 10 (ANI): A new drug candidate has been found to hold promise for cystic fibrosis patients.
Dr David Sheppard from the University of Bristol said that the early results with VX-770 suggest that drug therapies, which target defects at the root of the disease, have the potential to greatly improve the quality of life of CF patients.
Currently, there is no cure for CF caused due to a defective gene that causes ducts and tubes in the body to become blocked by thick, sticky mucus. This mucus affects the lungs, pancreas, the intestines, the liver and the reproductive organs. One of the most recognisable symptoms of CF is salty sweat, caused by the failure of the sweat ducts to reabsorb salt
The defective gene disables or destroys a protein known as CFTR.
The research team led by Sheppard is investigating how new drugs restore function to defective CFTR proteins.
The new drug therapy (VX-770) was developed by Vertex Pharmaceuticals and will tackle the functional defect.
The researchers have tested the drug on patients in the US who carry a genetic defect known as G551D.
The early results were encouraging. Patients who received 150mg twice a day saw the concentration of salt in their sweat decrease by almost 50 per cent and lung function improve by 10 per cent.
The study was presented at the BA Festival of Science in Liverpool. (ANI)
- Drug targets defective protein that causes cystic fibrosis - Nov 18, 2010
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- Protein involved in cystic fibrosis linked to chronic lung diseases - Dec 30, 2010
- Infliximab treatment effective for cystic fibrosis and Crohn's disease - Apr 20, 2010
- Crosstalk between ion channels leads to new therapeutic strategy - Sep 20, 2010
- Growth defects in patients with cystic fibrosis 'may start before birth' - Nov 10, 2010
- Scientists one step closer to a drug treatment for cystic fibrosis - Oct 13, 2010
- Common cold virus may help treat cystic fibrosis - Jul 21, 2009
- Boffins come closer to understanding how cystic fibrosis causes lung disease - Apr 29, 2010
- Human lungs can sweep out intruders - Aug 26, 2012
- Vitamin D may prevent or treat allergy to common mould - Aug 17, 2010
- Inhalation therapy proves effective against cystic fibrosis - Feb 06, 2009
- Scripps finding on DNA repair brings hope to cancer patients - Mar 28, 2011
- Vitamin D may treat allergy to common mold - Aug 26, 2010
- Model shows promise to develop therapies for protein folding diseases - Apr 28, 2011
Tags: ba festival, cf patients, cystic fibrosis, cystic fibrosis patients, david sheppard, defective gene, dr david, drug candidate, drug therapies, genetic defect, intestines, lung function, new drugs, pancreas, reproductive organs, salty sweat, sweat ducts, thick sticky mucus, university of bristol, vertex pharmaceuticals